Alumnus Wareham Honored with Lifetime Achievement Award
Alumnus Wareham Honored with Lifetime Achievement Award

John P. “Jack” Wareham, BSPha’64, HON’16John P. “Jack” Wareham, BSPS’56 received the fifth annual lifetime achievement award from the Advanced Medical Technology Association (AdvaMed), for his contributions to improving patient care and health care system efficiency through innovation of clinical laboratory testing. Wareham is the former CEO and chairman of Beckman Coulter. In 2016, Wareham received a Doctor of Pharmacy degree honoris causa from the School of Pharmacy and Health Professions.

“I am proud to be honored by my peers with this incredible award,” said Wareham, “and I gratefully accept on behalf of all the wonderful people I’ve worked with over the years who are dedicated to improving patient care.”

AdvaMed’s Lifetime Achievement Award highlights the accomplishments of pioneers in the medical technology sector whose contributions have had a significant impact on patients’ lives and the industry as an essential part of America’s economy. The award was presented on Sept. 27 during the MedTech Conference powered by AdvaMed in San Jose, California.

After graduating with a bachelor of science in pharmacy from Creighton, Wareham began his pharmacy career while simultaneously earning an MBA from Washington University in St. Louis, He then worked his way through the ranks of pharmaceutical company, Smith, Kline & French, now a part of GlaxoSmithKline (GSK).

Starting in 1984, Wareham held several senior management positions in a new division of Smith, Kline & French after it acquired laboratory instruments company Beckman Instruments in 1981. In 1993, he was named president and COO of Beckman Instruments, which was spun off as a separate, public company in 1989.

As COO, he was the driving force behind the successful merger in 1997 of Beckman Instruments with Coulter Corporation, the leading manufacturer of systems for blood and other cell analysis. In 1998, he was named CEO of the newly formed Beckman Coulter today recognized as a leader in the diagnostic industry.

After retiring from Beckman Coulter in 2005, Wareham continues to share his vision and business expertise, guiding medtech companies including Steris, ResMed, Accuray and Greatbatch.

Wareham also served as chairman of the Board for AdvaMed in 2000, leading the association in a new direction for the 21st century as it rebranded from the Health Industry Manufacturer’s Association.